 | Up a level |
Journal Article
Borchmann, P., Juehling, A., Goedel, P., Balke-Want, H., Schmid, C., Ayuk, F., Holtkamp, S., Preussner, L., Zadoyan, G., Hanssens, L., Kaiser, A., Jurk, M., Buerger, I, Schneider, D., Dropulic, B., Overstijns, T., Holtick, U., Scheid, C., Miltenyi, S. and Hallek, M. (2020). Phase I trial of MB-CART2019.1, a novel CD20 and CD19 targeting tandem chimeric antigen receptor, in patients with relapsed or refractory B-cell Non-Hodgkin Lymphoma. Oncol. Res. Treat., 43 (SUPPL 4). S. 56 - 57. BASEL: KARGER. ISSN 2296-5262
Prinz, J., Goedel, P., Shimabukuro-Vornhagen, A., Kochanek, M., Borchmann, P. and Boell, B. (2018). Immune-related toxicity syndromes in patients treated with chimeric antigen receptor T cell. Med. Klin.-Intensivmed Notfallmed., 113 (4). S. 329 - 331. NEW YORK: SPRINGER. ISSN 2193-6218
Prinz, J., Goedel, P., Shimabukuro-Vornhagen, A., von Bergwelt-Baildon, M., Kochanek, M., Borchmann, P. and Boell, B. (2018). Immune-related toxicity syndromes in patients treated with chimeric antigen receptor T cell therapy. Oncol. Res. Treat., 41. S. 87 - 88. BASEL: KARGER. ISSN 2296-5262
Prinz, J., d'Hargues, Y., Goedel, P., Shimabukuro-Vornhagen, A., Kochanek, M. and Boell, B. (2020). CARs, CRS and neurotoxicity: severe complications after administration of immunotherapy Essentials for intensivists. Med. Klin.-Intensivmed Notfallmed., 115 (3). S. 198 - 205. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2193-6226
d'Hargues, Y., Prinz, J., Goedel, P., Shimabukuro-Vornhagen, A., Kochanek, M. and Boell, B. (2020). y Diagnosis and treatment of immune-related adverse events during checkpoint inhibitor therapy in intensive care medicine. Med. Klin.-Intensivmed Notfallmed., 115 (4). S. 281 - 286. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2193-6226